-
Community_ Dr.Mostafa Akr_ 4
-
Community_ Dr.Mostafa Akr_ 5a
-
Community_ Dr.Mostafa Akr_ 5b
-
Community_ Dr.Mostafa Akr_ 6
-
Community_ Dr.Mostafa Akr_ 7
-
Community_ Dr.Mostafa Akr_ 8
-
Community_ Dr.Mostafa Akr_ 9
-
Community_ Dr.Mostafa Akr_ 10
-
Community_ Dr.Mostafa Akr_ 11
-
Community_ Dr.Mostafa Akr_ 12
-
Community_ Dr.Mostafa Akr_3
-
Community_ Dr.Mostafa Akr_ 13
-
Community_ Dr.Mostafa Akr_ 14
-
Community_ Dr.Mostafa Akr_ 2
-
Community_ Dr.Mostafa Akr_ 15
-
Community_ Dr.Mostafa Akr_1
-
Community_ Dr.Mostafa Akr_ 16
-
Community_ Dr.Mostafa Akr 2018_TB & hepatitis
-
Community_ Dr.Mostafa Akr_ 17
-
Community_ Dr.Mostafa Akr 2018_infection2 influenza
-
Community_ Dr.Mostafa Akr_ 18
-
Community_ Dr.Mostafa Akr 2018_ Infection scheme 1
-
Community_ Dr.Mostafa Akr_ 19
-
Community_ Dr.Mostafa Akr 2018_ Measles
-
Community_ Dr.Mostafa Akr_ 20
-
Community_ Dr.Mostafa Akr 2018_ TB & prevention scheme
-
Community_ Dr.Mostafa Akr_ 21
-
Community_ Dr.Mostafa Akr 2018_ Research methodology Study design
-
Community_ Dr.Mostafa Akr_ 22
-
Community_ Dr.Mostafa Akr 2018_ Attack Rate
-
Community_ Dr.Mostafa Akr_ 23
-
Community_ Dr.Mostafa Akr 2018_Investigation of infectious disease outbreak
-
Community_ Dr.Mostafa Akr_ 24
-
Community_ Dr.Mostafa Akr 2018_Scheme of Vaccine
-
Community_ Dr.Mostafa Akr 2018_ Measuring health & diseases
-
Community _ Dr. Mostafa Akar OSPE 1 Statistics Part 1
-
Community _ Dr. Mostafa Akar OSPE 1 Statistics Part 2
